- ABBV +0.22%
AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript
Yahoo Finance · 2 weeks ago
Open | 160.71 |
High | 161.44 |
Low | 160.35 |
Mkt Cap | 283.86B |
P/E (TTM) | 47.84 |
Div & Yield | 6.20 & 3.86% |
Prev. Close | 160.40 |
52 Wk. Low | 130.96 |
52 Wk. High | 182.89 |
Related stocks
Pharmaceutical company
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 12.31B | 0.70% ▲ |
Net Income | 1.37B | 472.80% ▲ |
Diluted EPS | 2.31 | 496.40% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $3.06 | - |
Q1 2024 | $2.23 | $2.31 |
Q4 2023 | $2.77 | $2.79 |
S&P FuturesES=F | 5,250.00+3.75 (+0.07%) |
Dow FuturesYM=F | 39,651.00+9.00 (+0.02%) |
Nasdaq FuturesNQ=F | 18,278.75+23.75 (+0.13%) |
81.150+4.11% | |
Tata Motors LimitedTATAMOTORS.NS | 960.05-8.27% |
Oklo Inc.OKLO | 8.45-53.65% |